Hawthorne effect with transient behavioral and biochemical changes in a randomized controlled sleep extension trial of chronically short-sleeping obese adults: Implications for the design and interpretation of clinical studies

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Cizza, Giovanni ^a   Piaggi, Paolo ^b   Rother, Kristina I ^c   Csako, Gyorgy ^d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ACTIMETRY; ADULT; ARTICLE; BEHAVIOR CHANGE; BIOCHEMICAL COMPOSITION; BLACK PERSON; BODY WEIGHT; CAUCASIAN; CONTROLLED STUDY; EPWORTH SLEEPINESS SCALE; FEMALE; GLUCOSE BLOOD LEVEL; HAWTHORNE EFFECT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PATIENT PARTICIPATION; PITTSBURGH SLEEP QUALITY INDEX; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SLEEP QUALITY; SLEEP THERAPY; SLEEP TIME; SOMNOLENCE; THERAPY EFFECT; ADOLESCENT; COMPLICATION; EPIDEMIOLOGY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SLEEP; SLEEP DISORDERS; YOUNG ADULT;

ACTIGRAPHY; ADOLESCENT; ADULT; EFFECT MODIFIER, EPIDEMIOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; RESEARCH DESIGN; SLEEP; SLEEP DISORDERS; YOUNG ADULT;

EID: 84912116265     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104176     Document Type: Article

References (32)

1. Hasler G, Buysse DJ, Klaghofer R, Gamma A, Ajdacic V, et al. (2004) The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 27:661-6. (Pubitemid 38823362)
2. McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, et al. (2009) Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr 49:868-913.
3. Roenneberg T, Allebrandt KV, Merrow M, Vetter C (2012) Social jetlag and obesity. Curr Biol 22:939-43.
4. Cappuccio FP, Taggart FM, Kandala NB, Currie A, Peile E, et al. (2008) Meta-analysis of short sleep duration and obesity in children and adults. Sleep 31:619-26. (Pubitemid 351694250)
5. Cizza G, Skarulis M, Mignot E (2005) A link between short sleep and obesity: building the evidence for causation. Sleep. 28:1217-20. (Pubitemid 41437877)
6. Ford ES, Li C, Wheaton AG, Chapman DP, Perry GS, et al. (2014) Sleep duration and body mass index and waist circumference among U.S. adults. Obesity (Silver Spring). 22:598-607.
7. Nedeltcheva AV, Kilkus JM, Imperial J, Schoeller DA, Penev PD (2010) Insufficient sleep undermines dietary efforts to reduce adiposity. Ann Intern Med. 53:435-41.
8. Chaput JP, Bouchard C, Tremblay A (2014) Change in sleep duration and visceral fat accumulation over 6 years in adults. Obesity (Silver Spring). 5:E9-E12.
9. Owens B (2013) Obesity: heavy sleepers. Nature. 497:S8-9.
10. Toor P, Kim K, Buffington CK (2012) Sleep quality and duration before and after bariatric surgery. Obes Surg 22:890-5.
11. Thomson CA, Morrow KL, Flatt SW, Wertheim BC, Perfect MM, et al. (2012) Relationship between sleep quality and quantity and weight loss in women participating in a weight-loss intervention trial. Obesity (Silver Spring). 20:1419-25.
12. Chaput JP, Tremblay A (2012) Sleeping habits predict the magnitude of fat loss in adults exposed to moderate caloric restriction. Obes Facts. 5:561-6.
13. Cizza G, Marincola P, Mattingly M, Williams L, Mitler M, et al (2010) Treatment of obesity with extension of sleep duration: a randomized, prospective, controlled trial. Clin Trials 3:274-85.
14. de Jonge L, Zhao X, Mattingly MS, Zuber SM, Piaggi P, et al. (2012) Poor sleep quality and sleep apnea are associated with higher resting energy expenditure in obese individuals with short sleep duration. J Clin Endocrinol Metab 97:2881-9.
15. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645.
16. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989); The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193-213.
17. Johns MW (1991) A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 14:540-545.
18. Roth T, Hull SG, Lankford DA, Rosenberg R, Scharf MB (2008) Intermezzo Study Group. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings. Sleep. 31:1277-84.
19. Ricós C, Alvarez V, Cava F, García-Lario JV, Hernández A, et al. (1999) Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 59: 491-500. (Pubitemid 30056739)
20. Hanlon EC, Van Cauter E (2011) Quantification of sleep behavior and of its impact on the cross-talk between the brain and peripheral metabolism. Proc Natl Acad Sci U S A. 108 Suppl 3:15609-16.
21. Yamaoka K, Tango T (2012) Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med. 10:138.
22. Kaneita Y, Uchiyama M, Yoshiike N, Ohida T (2008) Associations of usual sleep duration with serum lipid and lipoprotein levels. Sleep. 31:645-52. (Pubitemid 351694253)
23. Parsons HM (1974) What Happened at Hawthorne? New evidence suggests the Hawthorne effect resulted from operant reinforcement contingencies. Science 183: 922-32.
24. Schwartz D, Fischhoff B, Krishnamurti T, Sowell F (2013) The Hawthorne effect and energy awareness. Proc Natl Acad Sci U S A 110: 15242-6.
25. De Amici D, Klersy C, Ramajoli F, Brustia L, Politi P (2000) Impact of the Hawthorne effect in a longitudinal clinical study: the case of anesthesia. Contr Clin Trials 2:103-14. (Pubitemid 30129070)
26. Guerrero DM, Carling PC, Jury LA, Ponnada S, Nerandzic MM, et al. (2013) Beyond the Hawthorne effect: reduction of Clostridium difficile environmental contamination through active intervention to improve cleaning practices.Infect Control Hosp Epidemiol 34: 524-6.
27. Irvine J, Baker B, Smith J, Jandciu S, Paquette M, et al. (1999) Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Psychosom Med 61:566-75. (Pubitemid 29360322)
28. McCambridge J, Kypri K, Elbourne D (2014) Research participation effects: a skeleton in the methodological cupboard. J Clin Epidemiol Apr 21.
29. McCambridge J, Witton J, Elbourne DR (2014) Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol 3:267-77.
30. Bouchet C, Guillemin F, Briançon S (1996) Nonspecific effects in longitudinal studies: impact on quality of life measures. J Clin Epidemiol 49:15-20. (Pubitemid 26089544)
31. Quitkin FM, McGrath PJ, Stewart JW, Ocepek-Welikson K, Taylor BP, et al. (1998) Placebo run-in period in studies of depressive disorders. Clinical, heuristic and research implications. Br J Psychiatry. 173:242-8. (Pubitemid 28407458)
32. Carlino E, Pollo A, Benedetti F (2012) The placebo in practice: how to use it in clinical routine. Curr Opin Support Palliat Care. 6:220-5.